ELEV Elevation Oncology Inc
Price (delayed)
$0.6441
Market cap
$38.08M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.76
Enterprise value
$20.9M
Highlights
The EPS has surged by 64% year-on-year
Elevation Oncology's quick ratio has shrunk by 57% QoQ but it has increased by 40% YoY
ELEV's net income is up by 26% YoY but it is down by 6% QoQ
The debt has grown by 3.6% YoY
Key stats
What are the main financial stats of ELEV
Market
Valuations
Earnings
Shares outstanding
59.12M
Market cap
$38.08M
Enterprise value
$20.9M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.55
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$42.01M
Net income
-$41.95M
EBIT
-$41.15M
EBITDA
-$41.12M
Free cash flow
-$38.34M
Per share
Balance sheet
Liquidity
EPS
-$0.76
EPS diluted
-$0.76
Free cash flow per share
-$0.65
Book value per share
$1.17
Revenue per share
$0
TBVPS
$1.8
Total assets
$106.3M
Total liabilities
$36.95M
Debt
$31.02M
Equity
$69.36M
Working capital
$99.4M
Debt to equity
0.45
Current ratio
17.77
Quick ratio
17.39
Net debt/EBITDA
0.42
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-40.1%
Return on equity
-59.7%
Return on invested capital
-59%
Return on capital employed
-41%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ELEV stock price
How has the Elevation Oncology stock price performed over time
Intraday
0.62%
1 week
6.36%
1 month
-2.97%
1 year
-78.17%
YTD
14.49%
QTD
14.49%
Financial performance
How have Elevation Oncology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$42.01M
Net income
-$41.95M
Gross margin
N/A
Net margin
N/A
ELEV's net income is up by 26% YoY but it is down by 6% QoQ
Elevation Oncology's operating income has increased by 25% YoY but it has decreased by 6% QoQ
Growth
What is Elevation Oncology's growth rate over time
Valuation
What is Elevation Oncology stock price valuation
P/E
N/A
P/B
0.55
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 64% year-on-year
ELEV's P/B is 63% below its last 4 quarters average of 1.5
ELEV's equity is down by 14% since the previous quarter but it is up by 11% year-on-year
Efficiency
How efficient is Elevation Oncology business performance
ELEV's ROIC is up by 50% YoY
The return on equity rose by 43% year-on-year but it has declined by 2.9% since the previous quarter
Elevation Oncology's ROA has increased by 33% YoY but it has decreased by 4.2% from the previous quarter
Dividends
What is ELEV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ELEV.
Financial health
How did Elevation Oncology financials performed over time
The total assets is 188% greater than the total liabilities
Elevation Oncology's current ratio has plunged by 57% from the previous quarter but it has increased by 37% YoY
Elevation Oncology's quick ratio has shrunk by 57% QoQ but it has increased by 40% YoY
The debt is 55% less than the equity
The debt to equity has grown by 18% from the previous quarter but it has contracted by 6% YoY
ELEV's equity is down by 14% since the previous quarter but it is up by 11% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.